- Home
- HFBL vs BNR Comparison
HFBL vs BNR Comparison
Compare HFBL & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- BNR
- Stock Information
- Founded
- HFBL 1924
- BNR 2014
- Country
- HFBL United States
- BNR China
- Employees
- HFBL N/A
- BNR N/A
- Industry
- HFBL Savings Institutions
- BNR Medical Specialities
- Sector
- HFBL Finance
- BNR Health Care
- Exchange
- HFBL Nasdaq
- BNR Nasdaq
- Market Cap
- HFBL 41.3M
- BNR 38.3M
- IPO Year
- HFBL N/A
- BNR 2020
- Fundamental
- Price
- HFBL $13.25
- BNR $6.24
- Analyst Decision
- HFBL
- BNR
- Analyst Count
- HFBL 0
- BNR 0
- Target Price
- HFBL N/A
- BNR N/A
- AVG Volume (30 Days)
- HFBL 847.0
- BNR 58.0K
- Earning Date
- HFBL 07-29-2025
- BNR 08-21-2025
- Dividend Yield
- HFBL 3.78%
- BNR N/A
- EPS Growth
- HFBL 6.78
- BNR N/A
- EPS
- HFBL 1.26
- BNR N/A
- Revenue
- HFBL $20,802,000.00
- BNR $72,112,038.00
- Revenue This Year
- HFBL N/A
- BNR $136.32
- Revenue Next Year
- HFBL N/A
- BNR N/A
- P/E Ratio
- HFBL $10.40
- BNR N/A
- Revenue Growth
- HFBL 1.50
- BNR 0.53
- 52 Week Low
- HFBL $11.75
- BNR $2.18
- 52 Week High
- HFBL $14.25
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- HFBL 48.38
- BNR 58.58
- Support Level
- HFBL $13.52
- BNR $6.03
- Resistance Level
- HFBL $13.40
- BNR $7.80
- Average True Range (ATR)
- HFBL 0.07
- BNR 1.00
- MACD
- HFBL -0.04
- BNR -0.08
- Stochastic Oscillator
- HFBL 45.65
- BNR 32.51
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.